By examining the modulation of the NLRP3/caspase-1/GSDMD pyroptotic axis and the expression profiles of miR-675-5p and miR-1247-5p, this work provides new insights into the molecular mechanisms underlying their effects and advances the therapeutic prospects for PD and related neurodegenerative disorders. This evidence concerns the gene NLRP3 and Parkinson disease.